Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 10, 2023
TickeronGET DAILY SIGNALS
Stay Profitable in Volatile Markets: Tickeron's Best Robot of the Week Delivers strong performance and 1.7 Sharpe Ratio!

Stay Profitable in Volatile Markets: Tickeron's Best Robot of the Week Delivers strong performance and 1.7 Sharpe Ratio!

We can all agree that the past week has been a rollercoaster ride for traders. With major US stock market indexes experiencing drops ranging from -0.71 percent to -3.63 percent, it's clear that navigating market turbulence demands a sophisticated trading approach. That's why we're excited to introduce Tickeron's best-performing algorithm of the week, a true beacon of stability and consistent results.

Swing Trader: Medium Volatility Stocks for Active Trading (TA&FA)

Click to view full description and closed trades for free!

In times of sharp corrections like these, the ability to accurately assess market volatility and manage risks effectively becomes paramount. Tickeron's cutting-edge algorithm is precisely crafted to do just that, offering you the confidence you need in today's challenging trading environment.

What sets our top robot apart is its remarkable Sharpe ratio of 1.7, a testament to its ability to deliver consistent returns while efficiently managing risk. This stability and reliability are what every trader seeks, especially in unpredictable markets.

Click to view full description and closed trades for free!

Key highlights of Tickeron's top-performing algorithm:

  1. Stability and Consistency: This AI robot is tailor-made for traders who prefer stocks with medium volatility while aiming to avoid significant drawdowns during downtrends. How does it achieve this feat? By utilizing a well-crafted arsenal of technical indicators focused on identifying uptrend reversal points. This balanced approach enables the robot to navigate both short and long positions skillfully, reducing the risk of prolonged drawdowns.
  2. Precise Risk Management: What sets our robot apart is its proprietary method, developed by our team of quantitative analysts, which assesses the strength and quality of momentum in the most active stocks within the US market. Using a complex algorithm, this process involves a pool of technical indicators, meticulously analyzed through neural networks, to determine precise entry points for positions.
  3. Proven Results: Backed by a high Sharpe ratio of 1.7, our algorithm consistently delivers impressive results.

Navigating the market's ups and downs requires a trusted companion by your side, and Tickeron's algorithm is that reliable partner. It excels in identifying opportunities while protecting your investments, allowing you to focus on your trading strategies without the anxiety of market volatility.

Stay ahead of market turbulence with Tickeron - your path to stability and consistent results!

Here are the latest trades:

Related Ticker: FLNA, PHUN, BLNK, ACAD

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FLNA in downward trend: price dove below 50-day moving average on October 05, 2026

FLNA moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FLNA as a result. In 75 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for FLNA turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 40 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

The 10-day moving average for FLNA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for FLNA entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where FLNA advanced for three days, in 193 of 241 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

FLNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.344) is normal, around the industry mean (3.498). P/E Ratio (-0.520) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. FLNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FLNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.23B. The market cap for tickers in the group ranges from 58 to 138.67B. VRTX holds the highest valuation in this group at 138.67B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 3%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was 85%. INO experienced the highest price growth at 102%, while KPTI experienced the biggest fall at -92%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 0%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was -46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 44
Price Growth Rating: 66
SMR Rating: 93
Profit Risk Rating: 93
Seasonality Score: -4 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
20
Web
https://www.filanatx.com
Interact to see
Advertisement
The central stock price target of $100 is the arithmetic mean of the verified analyst price targets reviewed; major aggregators report a similar consensus near $99–$102, with a wide range from roughly $60 to $150. With the stock trading near $53, reaching $100 would require a gain of approximately 88% — a very large move from current levels.
The central $29 price target is the arithmetic mean of three verified, current analyst targets, rounded from an underlying average of about $28.67. With Groupon, Inc. (GRPN) recently trading near $16, reaching $29 would require a gain of roughly 80%, a very large move.
ON Semiconductor shares plunged -21.19% to $93.58 during Friday's regular session, extending a steep premarket selloff that began after Thursday's close. The primary catalyst was the announcement of a $7 billion all-stock acquisition of Synaptics (SYNA), with investors reacting negatively to significant shareholder dilution and the deal's strategic fit.
Exascale Labs Holdings is scaling a software-defined GPU (graphics processing unit) compute platform, with fiscal 2026 revenue rising 111% year over year to $14.8 million. A roughly $300 million qualified customer pipeline is the central forward-looking metric, though it has yet to be converted into signed contracts or recognized revenue.
NFT Limited (MI) rebounded +21.35% during regular market hours, trading near $1.08 versus the prior session's $0.89 close. The gain follows a steep -41.89% plunge the prior session after the company priced a dilutive 1 million-unit direct offering at $1.00 per unit.
Stay Profitable in Volatile Markets: Tickeron's Best Robot of the Week Delivers strong performance and 1.7 Sharpe Ratio!